Paper Details

  1. Home
  2. Paper Details

Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.

Author: BellStacie, CampanholoCristiano B, CorpNadia, CostaLuisa, DuarteGleison Vieira, DuruozMehmet T, GullickNicola J, KhraishiMajed, KishimotoMitsumasa, MaharajAjesh B, OgdieAlexis, Palmou-FontanaNatalia, ReddySoumya, ScarpaRaffaele, VegaLuis, ZismanDevy, de VlamKurt, van der WindtDanielle A

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

New treatment recommendations for psoriasis and psoriatic arthritis (PsA) provide guidance for choosing the right treatment based on each person's condition. In addition to specific features of the disease and related problems like eye inflammation and inflammatory bowel disease, other health conditions (comorbidities) also need to be considered when choosing the best treatment.
Paper Details　
Original Abstract of the Article :
The 2021 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations provide an evidence-based guide for selecting therapy based on the individual's disease features. Beyond the disease features and associated conditions (eg, uveitis and inflammatory bow...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.3899/jrheum.220310

データ提供：米国国立医学図書館（NLM）

Tailoring Treatment for Psoriatic Arthritis: A Guide to Managing Comorbidities

The [psoriatic arthritis] landscape is marked by its diversity, with individuals presenting with varying disease features and coexisting conditions. This study, informed by the [2021 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations], underscores the critical role of [comorbidities] in tailoring effective therapeutic strategies for [psoriatic arthritis] patients. The authors meticulously highlight the key considerations for selecting appropriate treatments, taking into account not only [disease features] but also [comorbidities] such as [uveitis] and [inflammatory bowel disease].

Optimizing Therapy: The Impact of Comorbidities on Psoriatic Arthritis Management

This research sheds light on the crucial role of [comorbidities] in shaping the treatment landscape for [psoriatic arthritis]. By recognizing the unique challenges posed by coexisting conditions, clinicians can develop more personalized and effective treatment plans. This tailored approach improves patient outcomes and reduces the risk of adverse events.

Personalized Care: A Key to Effective Psoriatic Arthritis Management

Imagine a vast desert, where each oasis possesses its unique characteristics. Similarly, each individual with [psoriatic arthritis] presents with a unique combination of [disease features] and [comorbidities]. This study underscores the importance of personalized care, where treatment strategies are carefully tailored to address the specific needs of each patient. This individualized approach fosters a more effective and efficient therapeutic journey.

Dr. Camel's Conclusion

This study emphasizes the importance of considering comorbidities when managing psoriatic arthritis. Just as a skilled desert traveler adapts their journey based on the terrain and resources, clinicians must tailor treatment plans to address the unique needs of each patient. By embracing a personalized approach, we can improve patient outcomes and optimize the management of this complex condition.

Date :
  1. Date Completed 2023-03-03
  2. Date Revised 2023-03-10
Further Info :

Pubmed ID

36319003

DOI: Digital Object Identifier

10.3899/jrheum.220310

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.